Defendant Name:
Cumberland Pharmaceuticals Inc.
Defendant Type:
Public Company
SIC Code:
2834
CUSIP:
23077010
Document Reference:
34-98553
Document Details
Legal Case Name
In the Matter of Cumberland Pharmaceuticals Inc.
Document Name
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
Document Date
27-Sep-2023
Document Format
Administrative Proceeding
Allegation Type
Other
Document Summary
On September 27, 2923, the SEC instituted settled cease-and-desist proceedings against Cumberland Pharmaceuticals Inc., stating: "These proceedings arise out of violations of the issuer reporting requirements and beneficial ownership reporting requirements of the federal securities laws."
Disgorgement & Penalty Information
Resolutions
Cease and Desist Order
Cooperation Before the Resolution
Remedial Acts or Efforts Before the Resolution
Monetary Penalties:
Civil Penalty
Individual:
$200,000.00
Shared:
